Abstract
The literature on the use of tricyclic antidepressants, serotonin specific reuptake inhibitors, monoamine oxidase inhibitors, benzodiazepines, propranolol, buspirone, and other medications for the treatment of childhood anxiety disorders is briefly reviewed. Issues requiring further research are identified. A detailed discussion of efficacy, dosing, safety concerns, and clinical management is presented for each class of medications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Child and Adolescent Psychiatric Clinics of North America
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
